Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 994 entries
View as:

Moderate to Severe Plaque Psoriasis With Scalp Involvement

Phase: N/A Priority: Normal
NCT ID: NCT00791765 Org: User:
Start: 10/31/08 End: 03/31/10 Due: 03/31/11

First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01568203 Org: User:
Start: 09/30/11 End: 06/30/12 Due: 06/30/13

Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia

Phase: N/A Priority: Normal
NCT ID: NCT02797080 Org: User:
Start: 06/28/16 End: 03/31/17 Due: 03/31/18

Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03836053 Org: User:
Start: 03/04/19 End: 04/21/22 Due: 04/21/23

Single and Multiple Ascending Dose Study of AMG 378 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06910709 Org: User:
Start: 04/08/25 End: 10/04/28 Due: 10/04/29

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00531284 Org: User:
Start: 09/30/07 End: 05/22/17 Due: 05/22/18

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT03298867 Org: User:
Start: 10/04/17 End: 11/30/20 Due: 11/30/21

A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00356681 Org: User:
Start: 12/31/06 End: 08/31/12 Due: 08/31/13

Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT02185911 Org: User:
Start: 06/30/14 End: 04/30/15 Due: 04/30/16

Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)

Phase: N/A Priority: Normal
NCT ID: NCT03780959 Org: User:
Start: 05/01/97 End: 07/08/98 Due: 07/08/99

Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia

Phase: N/A Priority: Normal
NCT ID: NCT00530114 Org: User:
Start: 03/31/08 End: 02/28/09 Due: 02/28/10

Phase II Study to Evaluate the Efficacy of AMG 317

Phase: N/A Priority: Normal
NCT ID: NCT00436670 Org: User:
Start: 03/31/07 End: 02/28/09 Due: 02/28/10

Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT00907478 Org: User:
Start: 08/11/09 End: 01/14/14 Due: 01/14/15

A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.

Phase: N/A Priority: Normal
NCT ID: NCT06079476 Org: User:
Start: 10/30/23 End: 10/21/25 Due: 10/21/26

Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator Reversibility

Phase: N/A Priority: Normal
NCT ID: NCT01902290 Org: User:
Start: 05/22/13 End: 05/15/15 Due: 05/15/16

Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents

Phase: N/A Priority: Normal
NCT ID: NCT00321711 Org: User:
Start: 10/01/06 End: 10/19/09 Due: 10/19/10

Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density

Phase: N/A Priority: Normal
NCT ID: NCT00043186 Org: User:
Start: 05/31/02 End: 06/30/07 Due: 06/30/08

Phase IIa Study of Fomepizole for Acetaldehyde Toxicity After Ethanol Exposure in Subjects With Altered Ethanol Metabolism

Phase: N/A Priority: Normal
NCT ID: NCT00661141 Org: User:
Start: 04/30/08 End: 06/30/08 Due: 06/30/09

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00110981 Org: User:
Start: 03/31/05 End: 03/31/06 Due: 03/31/07

Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT03422627 Org: User:
Start: 04/27/18 End: 10/13/22 Due: 10/13/23

A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT04761627 Org: User:
Start: 03/24/21 End: 02/28/23 Due: 02/28/24

Effect of Food on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01634178 Org: User:
Start: 02/01/12 End: 03/01/12 Due: 03/01/13

Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet

Phase: N/A Priority: Normal
NCT ID: NCT04191616 Org: User:
Start: 08/06/20 End: 10/01/24 Due: 10/01/25

AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).

Phase: N/A Priority: Normal
NCT ID: NCT04380753 Org: User:
Start: 04/28/20 End: 06/16/25 Due: 06/16/26

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4

Phase: N/A Priority: Normal
NCT ID: NCT02634580 Org: User:
Start: 02/27/16 End: 05/26/18 Due: 05/26/19